Emirati companies have announced their intention to introduce a new testing technology for the emerging coronavirus (Covid-19) for the Gulf countries and the Middle East, which is characterized by its ability to detect infection with the virus at its inception by 100%, and to detect the mutated strain of the virus (delta) by 99.4%.
Sheikh Sultan bin Saud Abdulaziz Al Mualla, CEO of the UAE company Cooper Diagnostics, said that the origin of the technology called (CRISPR), was presented by French researchers Emmanuel Charpentier and American Jennifer Doudna, as a global technology for detecting RNA as well as DNA in diagnostics in general, noting that The two researchers received the Nobel Prize in Chemistry last year in DNA technology, and later the diagnosis of the Covid-19 virus was invented.
He stated that the CRISPR technology obtained an emergency use license from the US Food and Drug Administration (FDA), as it is characterized by 100% accuracy and sensitivity in detecting the coronavirus during the first stage of infection, which contributes to the accuracy of diagnosis and improving the level of health care and treatment of the injured, noting that It also obtained the emergency license from the Ministry of Health and Community Protection in the country.
He pointed out that the tests conducted on the technology showed its success in detecting the Indian Delta strain of the Corona virus by 99.4%.
Sheikh Sultan Al Mualla added that the adoption of this technology in the UAE, as an emergency use, comes as a continuation of the state’s approach to developing health care services in an optimal way, in order to ensure the response to the “Corona” pandemic.
The Ministry’s Assistant Undersecretary for the Health Regulation Sector at the Ministry of Health and Community Protection, Dr. Amin Al-Amiri, confirmed that the Ministry is always keen to introduce and include the best international technologies in its services in the country, and that it was keen to issue an emergency use license for CRISPR technology upon receipt of the file with the emergency use license from the Drug Authority. and American Food, and it is keen to adopt new technologies to enhance the UAE’s leading role in combating the “Covid 19” pandemic.
The CEO and Managing Director of the UAE “Magenta” company, Dr. Zahid Al-Sabti, indicated that the new technology represents a qualitative leap in the accuracy of detecting the emerging corona virus, and it greatly outperforms all technologies currently used, in terms of 100% certainty in detecting the virus, and from In terms of speed of obtaining results, as the result appears within only 45 minutes, which makes it distinct from the rest of the tests currently available, which will enable it to enjoy high competitiveness in many areas such as airports, schools and other places of importance.